Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
RNA interference (RNAi) has an unprecedented potential as a therapeutic strategy for reversibly silencing the expression of any gene. Therapeutic delivery of the RNAi mediator, i.e., small interfering RNA (siRNA), can be used to address diseases characterized by gene overexpression, for example infl...
Main Authors: | Abhijeet Lokras, Aneesh Thakur, Abishek Wadhwa, Kaushik Thanki, Henrik Franzyk, Camilla Foged |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2020.601155/full |
Similar Items
-
Nanoparticles and siRNA: A new era in therapeutics?
by: María Dolores Pérez-Carrión, et al.
Published: (2024-03-01) -
Implications of siRNA Therapy in Bone Health: Silencing Communicates
by: Puneetpal Singh, et al.
Published: (2024-01-01) -
mRNA turnover rate limits siRNA and microRNA efficacy
by: Erik Larsson, et al.
Published: (2010-01-01) -
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
by: Dima Hattab, et al.
Published: (2021-07-01) -
Using RNAi in the treatment of cardiovascular diseases - therapeutics based on siRNA overview
by: Barbara Rusinowska
Published: (2022-08-01)